Price History

Hover for the daily close. The dotted line marks the period open.

Compare PFSA with… →

PFSA Key Statistics

As of Sep 4, 2026

Trading

Open: $2.55
Previous Close: $2.62
Day's Range: 2.55–2.87
52-Week Range: 2.49–4,500.00
Volume: 165.90K
Beta: 0.47

Valuation

Market Cap: $1.65M
P/E Ratio: unprofitable
EPS (ttm): −967.81

Financials (FY)

Revenue (FY): $0.00
Net Income (FY): −$35.82M
Profit margin: 0.00%
Shares Outstanding: 605.73K
1-Year Return: −99.56%

Dividend and dates

Avg Volume: 1.12M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

PFSA Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	−98.62%
2025 (partial year)	−95.80%

As of September 4, 2026.

PFSA Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$0.00	−$35.82M	—
2024	$0.00	−$9.23M	—
2023	$0.00	−$10.28M	—
2022	$0.00	−$20.22M	—

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$0.00	—	−$27.71M	−$35.82M	—
2024	$0.00	—	−$4.50M	−$9.23M	—
2023	$0.00	—	−$6.07M	−$10.28M	—
2022	$0.00	—	−$9.44M	−$20.22M	—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PFSA Valuation vs Medical Devices Median

Median of 151 stocks

Metric	PFSA	Medical Devices median	vs median
Profit margin	0.00%	−1.69%	1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Profusa, Inc. (PFSA) at $1.65M. It is classified in the Medical Devices industry, within the Healthcare sector.

PFSA last closed at $2.72 on September 4, 2026. That is +$0.10 (+3.82%) against the previous close. Over the past 52 weeks the price has ranged from $2.49 to $4,500.00. The latest close sits 9.24% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $0.00. The same year closed with a net loss of $35.82M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −967.81.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

Over the trailing twelve months the price has returned −99.56%. Beta against the wider market is reported at 0.47. Daily returns over the trailing 1 year annualize to a volatility of 695.02%.

Growth & Income

The record shows no dividend for PFSA.

So far in 2026 the price is −98.62%.

Peer Comparison

Profusa, Inc. (PFSA) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Profusa, Inc.	PFSA	$1.65M	—
Abbott Laboratories	ABT	$187.45B	35.1
Medtronic plc.	MDT	$120.46B	22.9
Stryker Corporation	SYK	$116.27B	31.9

The Medical Devices industry average P/E ratio is 26.8x. Profusa, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

MDT

Medtronic plc.

$120.46B

SYK

Stryker Corporation

$116.27B

BSX

Boston Scientific Corporation

$69.27B

EW

Edwards Lifesciences Corporation

$51.82B

DXCM

DexCom, Inc.

$33.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Profusa, Inc.

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Visit website →

Profusa, Inc. (PFSA) Stock Analysis